Back
CI Bio-Revolution Idx ETF Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
50
CDNA.TO
CI Bio-Revolution Idx ETF
Last Price:
17.73
Seasonality Move:
-4.65%
Sell
41
ASND
Ascendis Pharma AS
Last Price:
151.69
Seasonality Move:
6.54%
Sell
50
CI Bio-Revolution Idx ETF (CDNA.TO)
is a Sell
Is CI Bio-Revolution Idx ETF a Buy, Sell or Hold?
- The current CI Bio-Revolution Idx ETF [CDNA.TO] share price is $17.73. The Score for CDNA.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CDNA.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $148.89. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CDNA.TO Stock Price Chart
What is CI Bio-Revolution Idx ETF's stock price today?
-
The CI Bio-Revolution Idx ETF share price today is $17.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDNA.TO is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $148.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.
CDNA.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 94.34 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.73 - 17.73) | Sell |
Bollinger Bands (100): | (15.99 - 17.73) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 68.26 | Buy |
Chaikin Money Flow: | 280060 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.33 - 143.31) | Buy |
Bollinger Bands (100): | (125.42 - 139.7) | Buy |
CDNA.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.73 | Sell |
20-day SMA: | 17.73 | Sell |
50-day SMA: | 17.59 | Buy |
200-day SMA: | 16.89 | Buy |
8-day EMA: | 17.73 | Buy |
20-day EMA: | 17.71 | Buy |
50-day EMA: | 17.49 | Buy |
200-day EMA: | 17.06 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 126.6 | Buy |
20-day SMA: | 130.69 | Buy |
50-day SMA: | 132.91 | Buy |
200-day SMA: | 135.36 | Buy |
8-day EMA: | 133.29 | Buy |
20-day EMA: | 130.71 | Buy |
50-day EMA: | 131.94 | Buy |
200-day EMA: | 129.45 | Buy |
CI Bio-Revolution Idx ETF Earnings Growth & CDNA.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.76 per share, an increase next quarter of $1.52 per share, an increase this year of $1.66 per share, and an increase next year of $4.42 per share.
CI Bio-Revolution Idx ETF Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |